Skip to main content

  • Impact of Ticagrelor Versus Clopidogrel on Bleeding Outcomes of Isolated Coronary Artery Bypass Grafting

    • Posted: 01/19/2023
    • Author:

      Joseph J. Ingrassia, Wassim Mosleh, Chad M. Conner, Jeffrey F. Mather, Deborah S. Loya, David W. Yaffee, Trevor S. Sutton, Edmund T. Takata, Sean R. McMahon, Sabet W. Hashim and Raymond G. McKay

    • 2023CRM

    Abstract

    Background

    Increased bleeding risks have been documented in patients exposed to P2Y 12 inhibitors within 5 days of coronary artery bypass surgery (CABG). This study aimed to determine the relative CABG bleeding risks of clopidogrel versus ticagrelor exposure and the proper time course of ticagrelor discontinuation prior to surgery.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details